Patents Assigned to Collaborations Pharmaceuticals, Inc.
  • USE OF PYRONARIDINE, TILORONE, AND QUINACRINE AGAINST MARBURG VIRUS AND OTHER VIRUS INFECTIONS
    Publication number: 20240009183
    Abstract: Methods of treating or preventing diseases caused by viral infections via the administration of pyronaridine, quinacrine, and/or tilorone are described. The viral infections can be caused by viruses such as Marburg virus (MARV), Chikungunya virus (CHIKV), norovirus, Middle East Respiratory Syndrome coronavirus (MERS-CoV), and Nipah virus.
    Type: Application
    Filed: July 10, 2023
    Publication date: January 11, 2024
    Applicant: Collaborations Pharmaceuticals, Inc.
    Inventors: Sean Ekins, Thomas R. Lane, Ana C. Puhl
  • Use of pyronaridine, tilorone, and quinacrine against Marburg virus and other virus infections
    Patent number: 11696914
    Abstract: Methods of treating or preventing diseases caused by viral infections via the administration of pyronaridine, quinacrine, and/or tilorone are described. The viral infections can be caused by viruses such as Marburg virus (MARV), Chikungunya virus (CHIKV), norovirus, Middle East Respiratory Syndrome coronavirus (MERS-CoV), and Nipah virus.
    Type: Grant
    Filed: November 6, 2020
    Date of Patent: July 11, 2023
    Assignee: Collaborations Pharmaceuticals, Inc.
    Inventors: Sean Ekins, Thomas R. Lane, Ana C. Puhl Rubio
  • Methods and compositions for modulating ?-amyloid/?7-nAChR interactions
    Patent number: 11382875
    Abstract: Methods of modulating the interaction between ?-amyloid and ?7-nAChR are provided. Aspects of the methods include administering to the subject an effective amount of a naphthalene derivative active agent. Compositions and kits for practicing the subject methods are also provided. The methods, compositions and kits find use in treating a variety of applications, such as treating a subject for a neurodegenerative disease, e.g., Alzheimer's disease.
    Type: Grant
    Filed: April 5, 2018
    Date of Patent: July 12, 2022
    Assignees: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Collaborations Pharmaceuticals, Inc.
    Inventors: Aaron McMurtray, Julia Chung, Natalie Diaz, Sean Ekins